feed,title,long_url,short_url
Benzinga,Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance,https://benzinga.com/news/earnings/23/05/32286283/royalty-pharma-reaffirms-fy23-guidance-post-mixed-q1-performance,https://da.gd/Vc4Fev
